SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-048072
Filing Date
2014-06-24
Accepted
2014-06-24 17:16:34
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a14-12674_110q.htm 10-Q 719479
2 EX-31.1 a14-12674_1ex31d1.htm EX-31.1 11066
3 EX-31.2 a14-12674_1ex31d2.htm EX-31.2 11082
4 EX-32 a14-12674_1ex32.htm EX-32 10669
  Complete submission text file 0001104659-14-048072.txt   3894107

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT tbph-20140331.xml EX-101.INS 285168
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tbph-20140331.xsd EX-101.SCH 33736
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tbph-20140331_cal.xml EX-101.CAL 30935
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tbph-20140331_def.xml EX-101.DEF 157951
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tbph-20140331_lab.xml EX-101.LAB 1090208
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tbph-20140331_pre.xml EX-101.PRE 243719
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36033 | Film No.: 14938159
SIC: 2834 Pharmaceutical Preparations